معرفی
Matthew T. Rondina, MD, MS, is a Professor in the Departments of Internal Medicine (primary) and Pathology (adjunct) at the University of Utah. He serves as Director of Molecular Medicine at the University and Medical Director of the Thrombosis Service at the Salt Lake City VA Health Center. His research investigates inflammation-driven alterations in platelet and megakaryocyte gene expression, leveraging sequencing technologies and AI/ML for cancer diagnostics and sepsis outcomes.
Education
- M.S., Clinical Investigation, University of Utah
- Chief Medical Resident, Internal Medicine, University of Utah
- Residency, Internal Medicine, University of Utah Health Sciences Center
- Internship, Internal Medicine, University of Utah Health Sciences Center
- M.D., University of Utah Medical School
- B.S., Psychology, University of Utah
Research Focus
Dr. Rondina's laboratory explores: (1) inflammation-induced transcriptional changes in platelets/megakaryocytes; (2) functional impacts of gene expression on stem/peripheral blood compartments; (3) clinical outcomes in thrombotic/infectious diseases; and (4) AI/ML applications for early cancer detection using platelet RNA. His work bridges hematology, immunology, and computational biology.
Professional Leadership
- Board Certified in Internal Medicine
- Director, Molecular Medicine Program
- Medical Director, Thrombosis Service (VA Salt Lake City)
